ZUG, Switzerland, Nov. 21, 2024 /PRNewswire/ — SHL Medical, a world leader in self-injection solutions, today announced plans to establish SHL Advantec – a dynamic sub-group dedicated to providing tooling and automation solutions to the healthcare sector and other industries.
The establishment of SHL Advantec is part of SHL Medical’s ambitious expansion strategy and ongoing commitment to improving the lives of patients. The strategic move will allow SHL Medical to further focus on growing its business in self-injection devices while SHL Advantec provides advanced manufacturing and packaging technologies for medical devices and other healthcare products.
SHL Medical’s existing tooling and automation operations will be integrated into SHL Advantec, bringing their range of technologies, services, and equipment portfolio to the new business. Together with SHL Medical’s recent strategic acquisitions – Swiss-based LCA Automation and SMC Mould Innovation and US-based Superior Tooling – SHL Advantec will form a global operations network spanning three continents to deliver faster support and shorter supply chain services to SHL Advantec’s diverse customer base. Leveraging its experience in medical devices and other industries, SHL Advantec will focus on helping its customers advance production quality and resilience while continuing to support SHL Medical’s growth in autoinjector manufacturing.
“SHL Medical has always taken pride in being a true end-to-end solutions provider of autoinjector development and manufacturing, and part of that pride is built on our much-trusted tooling and automation solutions, which had been the backbone of SHL Medical’s ability to scale up production for our customers,” said Ulrich Faessler, CEO of SHL Medical. “As we prepare to pioneer the next era of innovative self-injection solutions, the strategic move will give SHL Medical and SHL Advantec the opportunity to maximize our strengths, both separately and collectively, to create more long-term value to our customers, their patients, and the entire pharmaceutical and healthcare value chain.”
SHL Advantec will be headquartered in Zug, Switzerland and will begin operations with over 600 dedicated employees across its offices and production sites in Switzerland, China, Taiwan, Mexico, and the US.
About SHL Medical
As a pioneering leader in self-injection solutions, SHL Medical is the partner of choice for many leading pharma and biotech companies. Driven by our company purpose – Enabling Patients’ Independence – we offer patient-centric solutions for the design, development, and manufacturing of autoinjectors, pen injectors, as well as innovative specialty delivery systems for large-volume and high-viscosity formulations. We also offer final assembly, labeling, and packaging solutions for our drug delivery systems.
In response to the rising trend in home therapy, SHL Medical has increased developmental work in the digital healthcare sector to help improve the drug delivery ecosystem.
Located across Switzerland, Taiwan, Sweden, and the US, our global team of experts collaborate seamlessly as one team in utilizing our comprehensive in-house manufacturing capabilities. Our solutions offer customization and optimization for each project while proactively weaving sustainability-driven measures into our designs and processes to contribute to a cleaner earth.
For additional information, visit www.shl-medical.com
Media contact
Carl Gillblad
Communications and Marketing
[email protected]
Customer inquiries
Gilbert Fluetsch
Commercial and Technical Services
[email protected]
Supplier relations
Joel Scheidegger
Supply Chain Management
[email protected]
Photo – https://mma.prnewswire.com/media/2563251/SHL_Medical.jpg
Photo – https://mma.prnewswire.com/media/2563252/SHL_Medical_SHL_Advantec.jpg
SOURCE SHL Medical
